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SUMMARY
Prosthetic joint infection is a dreaded complication of Total Joint Arthroplasty. Prevention, which 
is far more cost effective, should be of paramount importance to the arthroplasty surgeon. 
Proper patient selection and preparation as well as strict asepsis and antisepsis are the basic 
principles of prevention. 
INTRODUCTION
rosthetic Joint infection (PJI) is a dreaded 
Pcomplication of total joint arthroplasty (TJA) that carries signicant morbidity and 
mortality to patients. The reported incidence of PJI 
is 1-2% for total knee arthroplasty (TKA) and 0.3-
1.3% for total hip arthroplasty(THA); following 
revision arthroplasty however, it is as high as 5-6% 
1
and 3-4%for TKA and THA respectively.  This 
complication leads to prolonged hospital stay, 
readmission, repeated surgeries, loss of work 
hours and sometimes death. Mortality following 
PJI has been reported in some series to be as high 
2
as 7% in patients undergoing two stage revisions.
Worldwide, the cost of treatment of this condition 
is enormous. In Nigeria, treatment can be a huge 
burden on patients, as most times, they have to 
pay out of pocket for. The cost of primary TJA in 
Nigeria varies between 1-3 million Naira per joint, 
and the cost of revision TJA can be up to four times 
as high.
TJA is now increasingly offered to orthopedic 
patients in Nigeria many of whom are young 
patients with avascular necrosis (AVN) of femoral 
head secondary to sickle cell haemoglobinopathy. 
The exact number of TJA done in Nigeria is 
unknown as there is no central database. The 
exact incidence of PJI in these patients is still 
unknown. However, in our centre, no case of PJI 
has been recorded among 71 joints operated so far 
in past three years. Of the two cases of PJI we have 
treated so far, one was performed in an Indian 
hospital while the other was performed in a 
Nigerian hospital.
As TJA is increasingly performed, it is imperative 
that orthopedic surgeons and indeed the entire 
orthopedic community are aware of the methods 
and protocols for prevention of prosthetic joint 
infection with emphasis on issues peculiar to our 
environment. There are various practices for 
prevention in the literature, with different levels 
of evidence for recommendation.  We hereby 
review the best evidence for these practices and 
present our protocol at University College 
Hospital (UCH), Ibadan with the aim of providing 
safe and cost-effective recommendations.
CAUSATIVE ORGANISMS
The most commonly implicated organisms in PJI  
are S. aureus, S. epidermidis and coagulase 
negative staphylococcus (CNS) (35).+ At UCH, 
Ibadan the commonest organisms causing 
orthopedic implant related infections is S. aureus. 
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Clinical Practice 
Many of the organisms responsible for PJI are 
developing antibiotic resistance with methicillin 
resistant staphylococcus aureus (MRSA) being the 
most notable cause of PJI. Once the organisms 
form biolms on the prosthetic surface, they 
become virtually unreachable by systemic 
antibiotics and the host immune system. This 
further underscore the need for prevention.
PATIENT FACTORS
Patient co-morbidities are among the most 
important risk factors for PJI. As TJA is an elective 
procedure, it is mandatory to identify these risk 
factors and optimize the patients before surgery. 
The evaluation of these patients includes a 
thorough history, a meticulous physical 
examination and laboratory investigations.
Screening for infection
The presence of a local infection such as in the skin, 
subcutaneous tissue or deep in the joint can lead to 
direct seeding of the prosthesis and is an absolute 
6
contraindication to total joint arthroplasty.  Also, a 
systemic infection can lead to hematogenous 
seeding of the prosthesis and lead to a PJI.(7) It is 
therefore recommended that TJA be delayed until 
all possible sources of infection are identied and 
treated. A 6 to 12-month interval between 
eradication of a septic arthritis and TJA is 
8
recommended.  
MRSA carriers are identied by screening and 
h a v e  n a s a l  m u p i r o c i n  a n d  a   v e - d a y 
chlorhexidine wash for decolonization. Patients 
with athletes' foot on either limb are also identied 
and treated with an antifungal at least 3 weeks 
before surgery. A full blood count (FBC), C-
react ive  protein  (CRP)  and erythrocyte 
sedimentation rate (ESR) may suggest an 
infection; so also, a urinalysis. 
Urine cultures are only requested if a urinary tract 
infection (UTI) is suspected. Symptomatic UTI in 
association with urinary bacteria count greater 
3 than 1 x 10 /ml and leucocyte count greater than 1 
4 
x 10 /ml should be treated with appropriate 
antibiotics, and repeat culture should conrm 
eradication of infection before joint replacement is 
performed. Asymptomatic bacteriuria should not 
delay surgery but should be treated if bacteria 
3 9count is greater than 1 x 10 /ml .  Recurrent UTI in 
older men is likely due to underlying urinary 
outow obstruction. If there are lower urinary 
tract symptoms, the patient should have a urology 
review and appropriate treatment before TJA. 
Therefore, our patients routinely have a FBC, 
urinalysis and nasal swab culture.
Previous open joint surgery or previous joint 
trauma
Previous surgery or trauma involving the joint are 
associated with increased risk of PJI. This may be 
due to local wound healing concerns, difculty 
with dissection and potential prior contamination, 
all of which may predispose to development of a 
PJI. The International Consensus Group (ICG) on 
prevention of PJI, recommends that the surgical 
history be documented, the local wound 
environment analyzed and the surgical approach 
7and techniques be modied.
Skin Problems
It is important that the skin is intact at surgery. 
Active skin lesions, psoriasis, chronic venous 
ulcers, eczema, increase bacteria joint infection 
and PJI.(10,11) Psoriasis, eczema and other skin 
lesions may require dermatological review and 
treatment with surgery planned for when the skin 
condition is improved. Patients with chronic 
venous ulcers should be reviewed by a vascular 
surgeon and treated appropriately before surgery. 
There is a risk of recurrent ulceration following 
lower limb joint replacement, and advice on 
optimum perioperative management should be 
sought from a vascular surgeon.
Pre-morbid Medical Problems
Diabetes Mellitus
The incidence of type II diabetes is increasing 
worldwide. Nigeria is not exempt from this 
problem. Uncontrolled diabetes is linked with 
12, 13
surgical site infections (SSI) including PJI.  The 
ICG recommendation is to control diabetes before 
14, 15 
surgery (HbA1C of <7g/dl or FBS<180mg/dl).
Therefore, all patients are screened with a fasting 
blood sugar (FBS) and two hours post prandial 
(2HPP) blood sugar, while only diabetic patients 
have glycated hemoglobin (HbA1C) checked. 
There is also evidence that perioperative 
hyperglycemia increases the risk of PJI and this 
s h o u l d  b e  m o n i t o r e d  a n d  c o n t r o l l e d 
 15perioperatively.  Chronic diseases such as chronic 
renal failure and liver disease increase the risk of 
PJI. These conditions could be associated with low 
platelets, malnutrition and anemia that may 
necessitate allogeneic blood transfusion and its 
16attending risk.
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Rheumatoid arthritis and DMARDS
Earlier studies reported an increased risk of SSI 
and PJI with continual use of disease modifying 
anti rheumatic drugs(DMARDs) in patients with 
17 
rheumatoid arthritis. However, a more recent 
18study showed no increase in SSI in these patients.  
As a result, there are no clear recommendations; 
the ICG recommends cessation of DMARDS 
19
according to a schedule , while the WHO does not 
20recommend routine cessation.  It is best to work 
collaboratively with consultant rheumatologist to 
optimize patients perioperatively.
HIV Infection
The risk of PJI in patients with HIV is as high as 
21 14%. However, to our knowledge, there are no 
recommendations on ideal CD4 count before 
surgery in these patients. It however seems 
prudent to obtain virologist input on the optimum 
timing of surgery and perioperative management 
of these cases.
Nutritional status
The problems of malnutrition include prolonged 
22 23
hospital stay, delayed wound healing,  persistent 
24,25wound drainage and susceptibility to infection.  
Serum albumin, transferrin and prealbumin are 
some laboratory parameters for accessing 
malnutrition. However, only preoperative serum 
transferrin has been shown to correlate with 
23
delayed wound healing  while serum albumin 
<34g/L and tota l  lymphocyte  count  of 
<1200cells/ml are predictors of post operative 
2 2
adverse outcomes.  Clinical evidence of 
malnutrition is therefore sought in all patients and 
susceptible individuals are screened with 
albumin, transferrin or prealbumin.
Morbid Obesity
This carries an increased risk for all complications 
26, 28including PJI.  This may be due to longer 
operating time, larger incisions, difcult access, 
associated comorbidities and need for blood 
transfusion. A BMI of > 40kg/m2 carries an 
29 unacceptable risk for PJI and such patients should  
have weight reduction before TJA.
Depression
Patients with depression have an increased 
production of IL-6 which causes release of 
corticotropin releasing hormone (CRH) and then 
adrenocorticotropic hormone (ACTH). ACTH 
causes release of cortisol which inhibits the 
30 
immune response.  It is recommended that TJA 




Smoking cessation prior to surgery has been 
s h o w n  t o  d e c r e a s e  t h e  r i s k  o f  w o u n d  
32 complications and SSI. Although the optimal 
period of cessation is not well established, 





A systematic review on preoperative shower 
found no clear relationship between preoperative 
Chlorexidine gluconate (CHG) shower and 
33decrease in SSI.  Some other studies however, 
have shown it to decrease MRSA burden and 
34,35subsequent SSI.  The CDC and ICG endorse this 
36,37practice at least 24 hours prior to surgery.  
We recommend preoperative shower if patients 
are admitted earlier than the day before surgery 
and if they attend on the day, then antiseptic 
washing for a day before coming to hospital. 
Antiseptic soap may sufce.
Hair removal
There is no proven benet of shaving to decreasing 
38SSI.  If this is carried out in hairy individuals 
especially during THA, it should be done just 
before skin preparation, preferably in the 
induction room with a surgical hair clipper with 
39 disposable clipper head. We do not practice or 
recommend routine shaving for reducing 
infection risk. However, we shave the surgical 
eld if necessary, to ensure an adherent wound 
dressing and secure wound seal.
Operating room environment
Various studies  have demonstrated the 
importance of decreasing airborne bacteria in 
 40, 43
theatre.  This can be achieved by ventilation 
systems, limiting operating room (OR) trafc and 
personnel, theatre behavior and adequate 
44terminal cleaning of the operating room. 
Dedicated Orthopaedic Theatres
TJA involves the implantation of large metal and 
plastic implants into bone and tissues a process 
that can increase the virulence of bacteria more 
45than 100 thousand times.  It clearly cannot be 
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done in any theatre. The orthopaedic theatre used 
for TJA should not be shared with ENT, obstetrics 
and gynaecology, general surgery or urology 
where dirty surgery is the norm and unacceptable 
contamination is almost inevitable. The theatre 
should be large enough to accommodate all staff 
and equipment required for TJA. It should be 
adequately ventilated and well-lit. Equipment not 
required should be removed to reduce crowding 
as well as reduce generation of bacteria carrying 
particles. There should be running tap water in the 
scrub area for hand skin prep. 
There should ideally be an anesthetic induction 
room adjoining the main theatre area where 
patients are set up and activities such as shaving 
can be carried out before the patient is moved into 
theatre.  Patient positioning and application of 
supports to maintain the position can be done at 
this stage as can the application of plastic 
exclusion drape and preliminary skin preparation 
before proceeding into theatre.
Team Huddle and WHO Safety Checklist
All staff should come together to discuss the list 
before the start of surgery. The list is reviewed, 
and each case is discussed using the WHO safety 
checklist. This ensures patient safety, maximizes 
efciency while reducing the risk of complications 
including PJI.
Operating Room Trafc
The most commonly implicated bacteria in SSI are 
derived from skin ora, both patient and theatre 
staff. Studies have correlated the number of 
26
personnel in OR with bacterial count.  Increased 
trafc in and out of the OR also increases 
4 6turbulence, particle and bacteria count.  
However, there is no evidence on the optimal 
number of staff or door openings. The ICG 
recommendations are to limit the OR trafc, have 
all implants in the OR before start of surgery , use 
telephone to obtain information instead of 
entering the OR and avoid exchange of scrubbed 
44
personnel during surgery.  We recommend one 
surgeon with a maximum of three assistants, two 
anesthetists,  two scrub nurses and one 
circulating nurse.
Laminar Flow
The premise of the laminar ow system is that it 
lters the air coming into theatre of bacteria 
carrying particles thereby reducing the likelihood 
of joint infection from seeding of the wound by 
these bacteria carrying particles. This has been 
routine practice for many decades in many 
countries in the world where TJA practice is well 
established.
Recently evidence is emerging that challenges this 
presumed benet of laminar ow ventilation 
systems over conventional ones. Some studies 
have shown an increase in rate of SSI while others 
have shown a decrease; depending on whether 
vertical or horizontal, placement of personnel and 
 40,47,50the study design.  A review of the New 
Zealand TJA registry in 2011 even showed an 
increase in rate of early deep infection in hip 
51arthroplasty.  Furthermore a well-designed study 
has failed to show any  difference in the incidence 
of infection with the use of laminar ow systems 
52 
when compared with conventional systems.
We use a conventional ventilation system and a 
High Efciency Particulate Air(HEPA) lter. 
Operating room humidity and temperature is 
important in our environment as a tropical 
country. The temperature should be kept at 20 
degrees centigrade and low humidity.
Terminal Cleaning
The ICG recommends that the theatre oor, 
surfaces and furniture, operating lamp and any 




First generation cephalosporins e.g cefazolin or 
second generation cephalosporin e.g Cefuroxime 
53,54are the recommended prophylactic antibiotics.  
This is because of the good gram positive bacteria 
coverage, cost effectiveness  and excellent 
53
distribution.  The AAOS and ICG recommendation 
on vancomycin use is in MRSA carriers, penicillin 
anaphylaxis, institutionalized patients and 
53healthcare workers.  The administration is within 
1 hour of incision; however, extended infusion 
time antibiotics such as uoroquinolones and 
55
vancomycin should be started sooner.  If the 
surgery lasts more than 3 hours, a further dose 
should be given. Multiple guidelines recommend 
55,56
stoppage within 24hours.  It is paramount to 
observe all these precautions in preventing 
infection rather than continuing antibiotics 
beyond 24 hours as this confers no further gains in 
preventing infection and instead increases the risk 
55
of generating resistant organisms.
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Skin preparation and gowning – Surgical staff.
The head should be covered with the hair tucked 
in. There should be no fringes showing. 
Disposable face mask should be worn and both 
nose and mouth should be covered. The face mask 
should be changed for each procedure.
Surgical hand and forearm scrub by the scrub staff 
is an essential part of the surgical routine that has 
been shown to reduce the risk of SSI and has strong 
recommendation from all major guidelines 
generating institutes and orthopedic consensus 
57
groups.  The aim is to clear the skin of transient 
ora as well as reduce the volume of resident ora. 
The skin preparation should involve both hands, 
forearms, and elbows. It requires running tap 
water for effective skin preparation. The use of 
large basins of stagnant water for surgical hand 
skin prep is not acceptable and TJA should not be 
carried out in theatres without running tap water. 
Recommendation for hand prep is aqueous 
antiseptic soap. Chlorhexidine gluconate or 
Povidone iodine are commonly used. 
The skin should be prepared using antiseptic soap 
and soft disposable brush, paying attention to the 
nails and interdigital clefts. It is advisable that 
surgical staff should not keep nails and articial 
nails need to be removed as should nger and 
wrist jewelry. The area under the ngernail should 
be cleaned using a nail cleaner or a brush to ensure 
that there is no dirt. The skin cleansing should 
carry on past the elbow with the hand and forearm 
exed and under the tap and elbows dependent. 
There is evidence that skin prep as described for 3 
minutes or more results in eradication of transient 
bacteria and reduces resident bacteria by >90%. 
The hand and forearms are dried with the arms in 
the aforementioned positions and sterile 
disposable gowns are next worn with strict aseptic 
precautions followed by double gloving. 
Subsequent hand preparation can be carried out 
using this process each time or alcohol-based 
antiseptic hand rub can be used. The addition of 
alcohol to the antiseptic appears to increase its 
efcacy and this combination is recommended.
Changing of gloves should be considered after 
surgical site skin prep and draping but before 
application of plastic drape and at key stages of the 
surgery including reaming and rasping, handing 
58implants and wound closure.  Glove should also 
be changed when indicator inner gloves reveal  
perforation has occurred. Gloves should be 
changed when surgery lasts more than 2 and half 
59
hours .
Skin Preparation and Draping -Patient
CHG and povidone iodine are acceptable 
antiseptics for skin preparation as there is no 
evidence for one agent over another for 
37,60
prevention of SSI.  While CHG in alcohol is 
61superior to povidone iodine alone , there is no 
difference between the two when each is 
61combined with alcohol.  Therefore the CDC and 
ICG recommend that irrespective of which of the 2 
36,37agents is used, alcohol must be added.
In our practice, after positioning the patient, we 
wash the entire limb and adjoining areas with a 
s t e r i l e  g a u z e  s o a k e d  i n  C H G .  O u r 
recommendation is to prepare the whole limb 
63
including the foot .
After the surgical team are gowned, the whole 
limb is again prepared twice with 10% povidone 
iodine in alcohol starting with the operation eld 
and ending with the foot. The draping is done with 
strict aseptic precautions to expose the operation 
eld with the leg draped free. An iodine 
impregnated incise drape is also used over the 
operation site to prevent contamination. Although 
a systematic review had found no evidence that 
33
plastic adhesive drapes reduce rate of SSI , a large 
comparative study recently showed iodine 
impregnated incise drapes to have a cost effective 
benet in reducing SSI compared to the non-
62
iodine impregnated ones.  Considering that many 
theatres in Nigeria do not meet strict aseptic 
standards, we recommend the routine use of iodine 
impregnated incise drapes.
Surgeon arthroplasty volume and Surgical 
Duration
Several studies have clearly demonstrated that 
decreasing surgical duration decreases the rate of 
8,31,63,64SSI.  The number of TJA done by a hospital 
and the number done by the  surgeon per annum 
have a bearing on infection rates with low volume 
hospitals and low volume surgeons having higher 
65
rates of PJI.  It is recommended that solitary 
surgeons carrying out low volume occasional 
joint replacement, should be encouraged to visit 
larger volume centers to ensure that both their 
surgical skill and surgical volume are improved.
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Because perioperative allogenic blood transfusion 
 19,66is a risk for SSI and PJI , it is important to 
maximize blood conservation. Interventions may 
include identifying and treating the cause of 
anaemia, meticulous haemostasis during surgery 
and use of intravenous or topical tranexamic 
67,68
acid. In our practice, we administer 1g of i.v 
tranexamic acid routinely unless contraindicated 
one hour before incision. While closed drains are 
important to prevent hematoma collection, 
suction drains have been shown to increase 
69transfusion rate  which may increase the risk of 
SSI. Therefore, the ICG recommendation is to 
70remove drains if used, 24 hours after.  We tend to 
avoid drains, preferring to achieve meticulous 
haemostasis and close the wound in layers 
without drainage.
Pulsatile Lavage
A systematic review found pulsatile lavage to 
71reduce SSI compared to standard irrigation. We  
routinely use pulsatile lavage before placement of 
prosthesis and before wound closure in both THA 
and TKA.There is low quality evidence that intra-
operative irrigation with dilute antiseptic solution 
(Povidone iodine 0.35% or chlorhexidine 0.05 %) 
72
can reduce the risk of PJI.  This may be considered 
in addition to saline jet lavage irrigation in patients 
a t  h i g h  r i s k  o f  i n f e c t i o n  s u c h  a s 
Haemoglobinopathy, patients with inammatory 
arthritis and patients with diabetes.
Antibiotic loaded cement
Most, including all cement in our practice are 
already loaded with gentamicin. There are studies 
73,74
that suggest these may be effective.  However 
75,76routine use may lead to resistance.
POSTOPERATIVE CARE
Wound Management
There is no evidence to support one closure 
technique over another. The ICG recommends 
monolament non-absorbable sutures be used for 
77
skin closure.  It is important to eliminate dead 
space by closing the wound in layers. We use skin 
staples in our practice. The choice of wound 
78 
dressing has an inuence on wound healing.
Various studies have shown hydrobre or 
hydrocolloid dressings especially alginated 
hydrobres to decrease blister formation which 
may decrease SSI and PJI when compared to 
77,79routine gauze and adhesive dressings.
Application of wound dressing under stretch can 
cause shearing of the skin layers thus predisposing 
to blister formation around the wound. This can 
increase the risk of wound and joint infection. The 
dressing should be steri le ,  absorbent , 
impermeable and should be gently applied 
without stretch.
Prolonged hospitalization increase the risk of SSI 
including nosocomial infections with antibiotic 
80resistant organisms.  Efforts should be made to 
reduce the length of stay in hospital by pre-
operative optimization of co-mobidities, pre-
operative education and early mobilization by 
physiotherapy and adequate pain control using 
enhanced recovery protocols. Length of stay 
following uncomplicated surgery should not be 
longer than 4 days.
Management of the draining wound
Drainage from the wound lasting more than 
24hours should be managed with any of 
reinforced dressings, compressive wraps, 
negative pressure wound therapy, immobilization 
or absorbent dressing. Anticoagulants should also 
be stopped. If the drainage persists for more than 5 
days, the wound should be reopened, irrigated, 
77
debrided and closed.
Patients with joint replacement undergoing 
procedures known to generate transient 
bacteremia such as dental or urologic surgery 
should be given prophylactic antibiotic to protect 
the joint from hematogenous seeding. Also if they 
have any active local or systemic infection in this 
43should be promptly treated for the same reason.
INFECTION SURVEILLANCE
PJI Infection surveillance is important and any 
case of PJI particularly in the early post-operative 
period should be thoroughly investigated as this is 
likely to arise from inoculation intraoperatively. 
Adherence to these infection prevention 
guidelines should be monitored through regular 
audit of adherence to the guidelines. 
CONCLUSION
A prosthetic joint infection is a nightmare. The 
entire surgical staff should be aware of the various 
methods at prevention, the most important being 
proper patient selection/optimization and 
asepsis/antisepsis. 
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Ÿ Prevention of PJI infection is far better than 
attempts at its treatment and it is everyone's 
responsibility.
Ÿ Adoption of these recommendations does not 
involve signicant expense but a change of 
attitude.
Ÿ Greater Collaboration with other specialist 
colleagues is needed to optimize patients 
undergoing arthroplasty.
Ÿ Theatre team practice and behavior is one of the 
most important factors in reducing infection 
risk.
Ÿ Active peri-operative management including 
pre-operative optimization, optimum pain 
management and early mobilization is 
important in ensuring patients do not stay 
longer than necessary in hospital.
Ÿ Regular Audit and surveillance to reduce PJI 
infection should be instituted.
ABBREVIATIONS:
FBC: Full Blood Count
CRP: C-Reactive Protein
ESR: Erythrocyte Sedimentaion Rate
ICG: International Concensus Group
HbA1C: Glycated Hemoglobin
DMARDS: Disease Modifying Anti Rheumatic 
Drugs
HIV: Human Immunodeciency Virus
CD4: Colony of Differentiation 4
BMI: Body Mass Index
CRH: Corticotropin Releasing Hormone
ACTH: Adrenocorticotropic Hormone
CDC: Centre for Disease Control (America)
ENT: Ear, Nose and Throat (surgery)
WHO: World Health organization
AAOS: American Academy of Orthopedic 
Surgeons
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